CORRELATION FINDINGS AND FREQUENCY OF CALR EXON 9 MUTATIONS IN WILD TYPE JAK2 BCR-ABL-NEGATIVE MPN PATIENTS

被引：0

作者：

Limsuwanachot, Nittaya ^{[1
]}

Rerkamnuaychoke, Budsaba ^{[1
]}

Chareonsirisuthigul, Takol ^{[1
]}

Chancharunee, Suporn ^{[2
]}

Siriboonpiputtana, Teerapong ^{[1
]}

机构：

[1] Human Genet Lab, Bangkok, Thailand

[2] Ramathibodi Hosp, Div Hematol, Bangkok, Thailand

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2016年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 64

页数：1

共 50 条

[21] Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Pietra, Daniela
Li, Sai
Brisci, Angela
Passarnonti, Francesco
Rumi, Elisa
Theocharides, Alexandre
Ferrari, Maurizio
Gisslinger, Heinz
Kralovics, Robert
Cremonesi, Laura
Skoda, Radek
Cazzola, Mario
BLOOD, 2008, 111 (03) : 1686 - 1689
[22] Design and Validation of a CALR Fragment Analysis Assay for Patients with Myeloproliferative Neoplasm and Negative for JAK2 Mutations
de Abreu, F. B.
Soares, B. I.
dos Santos, L. L.
Kaur, P.
Ornstein, D. L.
Tsongalis, G. J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 779 - 779
[23] JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms
Soliman, Eman A.
El-Ghlban, Samah
Abd El-Aziz, Sherin
Abdelaleem, Abdelaleem
Shamaa, Sameh
Abdel-Ghaffar, Hassan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : E645 - E651
[24] Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients
Kouroupi, Eirini
Zoi, Katerina
Parquet, Nathalie
Zoi, Christine
Kiladjian, Jean-Jacques
Grigoraki, Vassiliki
Vainchenker, William
Lellouche, Franck
Marzac, Christophe
Schlageter, Marie-Helene
Dosquet, Christine
Scott, Linda M.
Fenaux, Pierre
Loukopoulos, Dimitris
Chomienne, Christine
Cassinat, Bruno
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (04) : 676 - 679
[25] JAK2 V617F and Exon 12 Genetic Variations in Korean Patients with BCR/ABL1-negative Myeloproliferative Neoplasms
Kim, Jeong Tae
Cho, Yong Gon
Choi, Sam Im
Lee, Young Jin
Kim, Hye Ran
Jang, Sook Jin
Moon, Dae Soo
Park, Young Jin
Park, Geon
KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (06): : 567 - 574
[26] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
Tanja Belcic Mikic
Tadej Pajic
Matjaz Sever
Scientific Reports, 9
[27] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
Mikic, Tanja Belcic
Pajic, Tadej
Sever, Matjaz
SCIENTIFIC REPORTS, 2019, 9 (1)
[28] JAK2 INHIBITORS AND WHAT COMES NEXT FOR PATIENTS WITH BCR-ABL1-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Mughal, Tariq I.
LEUKEMIA RESEARCH, 2017, 61 : S8 - S8
[29] Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR
Wang, Zhanlong
Tian, Xin
Ma, Jinyu
Zhang, Yuhui
Ta, Wenru
Duan, Yifan
Li, Fengli
Zhang, Hong
Chen, Long
Yang, Shaobin
Liu, Enbin
Lin, Yani
Yuan, Weiping
Ru, Kun
Bai, Jie
CANCER MEDICINE, 2024, 13 (07):
[30] JAK2 exon 12 mutations in patients with Philadelphia(Ph) chromosome-negative myeloproliferative neoplasms
王婕妤
ChinaMedicalAbstracts(InternalMedicine), 2012, 29 (04) : 234 - 234

← 1 2 3 4 5 →